FEB 22, 2018 11:00 PM PST
Pivot Pharma to Acquire Agro-Biotech for Full Spectrum Medical Cannabis Organization in Canada
WRITTEN BY: Mauri Brueggeman
2 4 228

Photo Source: beaverbud.com

Canadian cannabis industry companies Pivot Pharmaceuticals and Agro-Biotech made news on February 22, 2018 when Pivot announced the proposed acquisition of Agro-Biotech.  Pivot Pharma is known for its drive to improve dosing and bioavailability of cannabinoids and holds several patents for its unique delivery technologies.  Agro-Biotech is one of six licensed producers of medical cannabis in Quebec, Canada with numerous cannabis strains including those with high levels of cannabidiol (CBD).  With this proposed transaction, Pivot Pharma will be able to manage and direct the entire process from seed to consumer.   

Pivot Pharmaceuticals’ medical cannabis division, Pivot Green Stream Health Solutions (PGS), already conducts research and supports new development and commercialization of its products; Agro-Biotech can bring their expertise and experience as a grower and producer of medical cannabis to help Pivot further innovate and drive medical cannabis research efforts.  PGS’s mission is to develop novel treatments to address unmet healthcare needs.  Pivot recently procured worldwide rights for two proprietary drug delivery methods for cannabinoid, cannabidiol and tetrahydrocannabinol products.

Canada legalized medical cannabis in 2001 and under Health Canada, the country’s equivalent to the US Department of Health and Human Services, they have worked to keep a steady balance of approved growers with licenses to have a supply to sufficiently meet demand.  Canada also established the Canadian Consortium for the Investigation of Cannabinoids (CCIC) which is a federally approved nonprofit organization bringing scientists and clinical researchers together with health care professionals to promote evidence based research surrounding the application of endocannabinoids and phytocannabinoids.  CCIC has an annual conference focused on cannabinoids in clinical practice scheduled for April 2018.

The cannabis science industry is growing rapidly in many areas of the world; it is not surprising for companies in niche marketplaces or specific sectors within the industry to collaborate and keep momentum going.  As countries consider changes to medical cannabis laws and/or drug classification, companies working together or acquiring one another might lead to quicker change and therefore, more research on the risks and benefits of medicinal cannabis.

Sources: Pivot/Biotech Proposal Letter of IntentPivot Green Stream Health Solutions (PGS)Canadian Consortium for the Investigation of Cannabinoids (CCIC)

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
JUN 23, 2016
Cannabis Sciences
JUN 23, 2016
Canada Looks at Teen Pot Use and the Brain
The question of whether or not to legalize marijuana is controversial, with experts weighing in on both sides of the issue. While it’s well known tha
DEC 01, 2017
Cannabis Sciences
DEC 01, 2017
Medical Cannabis: Types of Consumption
Learn about the many different methods you can use to consume medical cannabis.
MAR 27, 2018
Cannabis Sciences
MAR 27, 2018
Medicinal Cannabis: Commonly Used Terms Part 1
Part one in a series of commonly used terms related to medical marijuana.
APR 05, 2018
Cannabis Sciences
APR 05, 2018
How the Endocannabinoid System was Discovered
Currently, in the United States, forty-six states and three territories have some form of a medical cannabis program. This has been a long struggle for adv
MAY 04, 2018
Cannabis Sciences
MAY 04, 2018
Cannabis and Drug Interactions
Cannabis is known to inhibit the cytochrome enzymes P450.  This family of enzymes metabolizes more than half of all pharmaceuticals, including the phy
JUN 05, 2018
Cannabis Sciences
JUN 05, 2018
Marijuana during pregnancy may result in smaller babies
Marijuana use during pregnancy may have consequences for infants’ weight and behavior, particularly in combination with tobacco use. Smoking during p
Loading Comments...